SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. Business Segments Shenyang Xingqi Pharmaceutical Co.,Ltd.
Equities
300573
CNE100002DV1
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 69.85 CNY | -2.82% |
|
-9.06% | -46.36% |
Sales 2023 by Business Segment
Sales 2023 by Geography
Historical Breakdown of Revenue by Business Segments
: Breakdown by Business Segment
| Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Manufacturing | - | 546M | 707M | 821M | 1.09B | |||||
Medical Service | - | 138M | 317M | 406M | 351M | |||||
Other Operations | - | 5.46M | 3.81M | 23.2M | 27.86M | |||||
Medicine Manufacturing | 542M | - | - | - | - | |||||
Interest Expense | -4.46M | - | - | - | - | |||||
Income Tax Expense | 6.31M | - | - | - | - | |||||
Total Assets | 852M | - | - | - | - | |||||
CAPEX | -69.98M | - | - | - | - | |||||
EBT | 35.82M | - | - | - | - | |||||
D&A | 40.23M | - | - | - | - | |||||
Operating Income | 37.69M | - | - | - | - | |||||
Net Income | 35.89M | - | - | - | - |
Geographical Revenue Distribution History
| Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
China | 542M | 689M | 1.03B | 1.25B | 1.47B | |||||
Total Assets | 852M | 966M | 1.69B | 1.78B | 2.02B | |||||
Interest Expense | -4.46M | -5.94M | -5.99M | -937K | -1.44M | |||||
Income Tax Expense | 6.31M | 9.08M | 34.43M | 22.03M | 24.96M | |||||
D&A | 40.23M | 44.82M | 66.57M | 72.61M | 86.28M | |||||
CAPEX | -69.98M | -108M | -95.06M | -299M | -262M | |||||
Net Income | 35.89M | 87.98M | 195M | 212M | 240M | |||||
EBT | 35.82M | 103M | 244M | 234M | 265M | |||||
Operating Income | 37.69M | 106M | 248M | 250M | 277M |
MarketScreener is also available in this country: United States.
Switch edition